Cancer Biotherapy and Radiopharmaceuticals

期刊简介：Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.

【译文】癌症生物治疗和放射性药物是经过同行评审的期刊，已有超过25年的前沿内容，专注于创新的治疗研究，旨在最终改善癌症管理。它是唯一专注于癌症生物治疗的期刊，包括单克隆抗体、细胞因子治疗、癌症基因治疗、基于细胞的疗法和其他形式的免疫治疗。该期刊广泛报道了放射性免疫治疗的进展，以及放射性药物和放射性标记肽在开发新的癌症治疗方法中的应用。